Skip to main content
Erschienen in: European Journal of Medical Research 1/2015

Open Access 01.12.2015 | Retraction Note

Retraction Note: Joint detection of ERCC1, TUBB3, and TYMS guidance selection of docetaxel, 5-fluorouracil and cisplatin (DDP) individual chemotherapy in advanced gastric cancer patients

verfasst von: Yushuang Luo, Zhanquan Li, Sen Cui, Cunfang Shen, Junhui Zhao, Milu Wu, Yuying Li, Miaozhou Wang, Rong Chen, Zhibo Liu, Ge Ri-li

Erschienen in: European Journal of Medical Research | Ausgabe 1/2015

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise
The online version of the original article can be found under doi:10.​1186/​s40001-014-0050-z.
The online version of the original article can be found at http://​dx.​doi.​org/​10.​1186/​s40001-014-0050-z.

Retraction

The Publisher and Editor regretfully retract this article [1] because the peer-review process was inappropriately influenced and compromised. As a result, the scientific integrity of the article cannot be guaranteed. A systematic and detailed investigation suggests that a third party was involved in supplying fabricated details of potential peer reviewers for a large number of manuscripts submitted to different journals. In accordance with recommendations from COPE we have retracted all affected published articles, including this one. It was not possible to determine beyond doubt that the authors of this particular article were aware of any third party attempts to manipulate peer review of their manuscript.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
The Creative Commons Public Domain Dedication waiver (https://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
download
DOWNLOAD
print
DRUCKEN
Literatur
1.
Zurück zum Zitat Luo Y, Li Z, Cui S, Shen C, Zhao J, Wu M, et al. Joint detection of ERCC1, TUBB3, and TYMS guidance selection of docetaxel, 5-fluorouracil and cisplatin (DDP) individual chemotherapy in advanced gastric cancer patients. Eur J Med Res. 2014;19:50.CrossRefPubMedCentralPubMed Luo Y, Li Z, Cui S, Shen C, Zhao J, Wu M, et al. Joint detection of ERCC1, TUBB3, and TYMS guidance selection of docetaxel, 5-fluorouracil and cisplatin (DDP) individual chemotherapy in advanced gastric cancer patients. Eur J Med Res. 2014;19:50.CrossRefPubMedCentralPubMed
Metadaten
Titel
Retraction Note: Joint detection of ERCC1, TUBB3, and TYMS guidance selection of docetaxel, 5-fluorouracil and cisplatin (DDP) individual chemotherapy in advanced gastric cancer patients
verfasst von
Yushuang Luo
Zhanquan Li
Sen Cui
Cunfang Shen
Junhui Zhao
Milu Wu
Yuying Li
Miaozhou Wang
Rong Chen
Zhibo Liu
Ge Ri-li
Publikationsdatum
01.12.2015
Verlag
BioMed Central
Erschienen in
European Journal of Medical Research / Ausgabe 1/2015
Elektronische ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-015-0134-4

Weitere Artikel der Ausgabe 1/2015

European Journal of Medical Research 1/2015 Zur Ausgabe